The effect of atorvastatin on lung histopathology in a murine model of chronic asthma

Area of Science:

• Pharmacology
• Immunology
• Pulmonology

Background:

• Statins, like atorvastatin, are known for cholesterol reduction and possess anti-inflammatory and immunomodulating properties.
• Asthma is a chronic inflammatory airway disease characterized by airway hyperresponsiveness and reversible airflow obstruction.
• The independent effects of statins on asthma pathology require further investigation.

Purpose of the Study:

• To evaluate the impact of atorvastatin on lung tissue histological alterations in a murine model of chronic asthma.
• To assess the anti-inflammatory effects of atorvastatin in asthma by measuring specific cytokine levels.

Main Methods:

• A chronic asthma model was established in BALB/c mice sensitized with ovalbumin.
• Mice received intraperitoneal injections of saline, atorvastatin (10mg/kg), or dexamethasone (1mg/kg) for five consecutive days.
• Lung tissues were analyzed using light and electron microscopy, and levels of Interleukin-4 (IL-4) and Interleukin-5 (IL-5) were measured.

Main Results:

• Atorvastatin treatment significantly reduced basement membrane thickness, subepithelial smooth muscle layer, epithelial height, and mast and goblet cell counts compared to placebo.
• The observed histological improvements with atorvastatin were comparable to those achieved with dexamethasone.
• Atorvastatin significantly decreased IL-4 and IL-5 levels in lung tissue compared to the placebo group.

Conclusions:

• Atorvastatin demonstrates significant beneficial effects on lung histological changes in a chronic asthma mouse model.
• The anti-inflammatory actions of atorvastatin, indicated by reduced IL-4 and IL-5, contribute to its therapeutic potential in asthma.
• Atorvastatin represents a potential therapeutic agent for managing histological and inflammatory aspects of chronic asthma.